Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Fosphenytoin
Homo sapiens
Drug Action Pathway
Fosphenytoin is an anticonvulsant used for generalized convulsive status epilepticus to prevent treatment of seizures during surgery. Fosphenytoin is a water soluble phenytoin prodrug, it acts by slowing down impulses in the brain reducing neuronal activity and avoiding a seizure. It blocks neuronal sodium channels to limit repetitive firing of action potentials. Once administered fosphenytoin is acted upon by endogenous phosphatases to be converted into phenytoin that acts to apply the anticonvulsant properties and inhibit channel activity. It inhibits by promoting sodium efflux which stabilizes the channel against hyperexcitability. It is excreted through the urine as 5-phenylhydantoin. Adverse effects that could come from administration is nausea, vomiting, lethargy, tachycardia, bradycardia, cardiovascular complications, metabolic acidosis and in some cases overdosage can result in death.
References
Fosphenytoin References
Fischer JH, Patel TV, Fischer PA: Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42(1):33-58. doi: 10.2165/00003088-200342010-00002.
Pubmed: 12489978
Boucher BA: Fosphenytoin: a novel phenytoin prodrug. Pharmacotherapy. 1996 Sep-Oct;16(5):777-91.
Pubmed: 8888074
Luer MS: Fosphenytoin. Neurol Res. 1998 Mar;20(2):178-82. doi: 10.1080/01616412.1998.11740502.
Pubmed: 9522355
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Settings